Literature DB >> 29593035

A Highly Conserved Leucine in Mammarenavirus Matrix Z Protein Is Required for Z Interaction with the Virus L Polymerase and Z Stability in Cells Harboring an Active Viral Ribonucleoprotein.

Masaharu Iwasaki1, Juan C de la Torre2.   

Abstract

Mammarenaviruses cause chronic infections in their natural rodent hosts. Infected rodents shed infectious virus into excreta. Humans are infected through mucosal exposure to aerosols or direct contact of abraded skin with fomites, resulting in a wide range of manifestations from asymptomatic or mild febrile illness to severe life-threatening hemorrhagic fever. The mammarenavirus matrix Z protein has been shown to be a main driving force of virus budding and to act as a negative regulator of viral RNA synthesis. To gain a better understanding of how the Z protein exerts its several different functions, we investigated the interaction between Z and viral polymerase L protein using the prototypic mammarenavirus, lymphocytic choriomeningitis virus (LCMV). We found that in the presence of an active viral ribonucleoprotein (vRNP), the Z protein translocated from nonionic detergent-resistant, membrane-rich structures to a subcellular compartment with a different membrane composition susceptible to disruption by nonionic detergents. Alanine (A) substitution of a highly conserved leucine (L) at position 72 in LCMV Z protein abrogated Z-L interaction. The L72A mutation did not affect the stability or budding activity of Z when expressed alone, but in the presence of an active vRNP, mutation L72A promoted rapid degradation of Z via a proteasome- and lysosome-independent pathway. Accordingly, L72A mutation in the Z protein resulted in nonviable LCMV. Our findings have uncovered novel aspects of the dynamics of the Z protein for which a highly conserved L residue was strictly required.IMPORTANCE Several mammarenaviruses, chiefly Lassa virus (LASV), cause hemorrhagic fever disease in humans and pose important public health concerns in their regions of endemicity. Moreover, mounting evidence indicates that the worldwide-distributed, prototypic mammarenavirus, lymphocytic choriomeningitis virus (LCMV), is a neglected human pathogen of clinical significance. The mammarenavirus matrix Z protein plays critical roles in different steps of the viral life cycle by interacting with viral and host cellular components. Here we report that alanine substitution of a highly conserved leucine residue, located at position 72 in LCMV Z protein, abrogated Z-L interaction. The L72A mutation did not affect Z budding activity but promoted its rapid degradation in the presence of an active viral ribonucleoprotein (vRNP). Our findings have uncovered novel aspects of the dynamics of the Z protein for which a highly conserved L residue was strictly required.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  RNA-dependent RNA polymerase; arenavirus; matrix protein; protein stability

Mesh:

Substances:

Year:  2018        PMID: 29593035      PMCID: PMC5952140          DOI: 10.1128/JVI.02256-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV-like particles.

Authors:  Ki Jeong Lee; Mar Perez; Daniel D Pinschewer; Juan Carlos de la Torre
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

Review 2.  Treatment of arenavirus infections: from basic studies to the challenge of antiviral therapy.

Authors:  Elsa B Damonte; Celia E Coto
Journal:  Adv Virus Res       Date:  2002       Impact factor: 9.937

3.  Myristoylation of the RING finger Z protein is essential for arenavirus budding.

Authors:  Mar Perez; Dori L Greenwald; Juan Carlos de la Torre
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

Review 4.  Exotic emerging viral diseases: progress and challenges.

Authors:  Thomas W Geisbert; Peter B Jahrling
Journal:  Nat Med       Date:  2004-12       Impact factor: 53.440

5.  Transmission of lymphocytic choriomeningitis virus by organ transplantation.

Authors:  Staci A Fischer; Mary Beth Graham; Matthew J Kuehnert; Camille N Kotton; Arjun Srinivasan; Francisco M Marty; James A Comer; Jeannette Guarner; Christopher D Paddock; Dawn L DeMeo; Wun-Ju Shieh; Bobbie R Erickson; Utpala Bandy; Alfred DeMaria; Jeffrey P Davis; Francis L Delmonico; Boris Pavlin; Anna Likos; Martin J Vincent; Tara K Sealy; Cynthia S Goldsmith; Daniel B Jernigan; Pierre E Rollin; Michelle M Packard; Mitesh Patel; Courtney Rowland; Rita F Helfand; Stuart T Nichol; Jay A Fishman; Thomas Ksiazek; Sherif R Zaki
Journal:  N Engl J Med       Date:  2006-05-25       Impact factor: 91.245

Review 6.  Congenital lymphocytic choriomeningitis virus infection: decade of rediscovery.

Authors:  L L Barton; M B Mets
Journal:  Clin Infect Dis       Date:  2001-07-05       Impact factor: 9.079

7.  NMR assignment of the arenaviral protein Z from Lassa fever virus.

Authors:  Laurent Volpon; Michael J Osborne; Katherine L B Borden
Journal:  Biomol NMR Assign       Date:  2008-06       Impact factor: 0.746

8.  Structural characterization of the Z RING-eIF4E complex reveals a distinct mode of control for eIF4E.

Authors:  Laurent Volpon; Michael J Osborne; Althea A Capul; Juan C de la Torre; Katherine L B Borden
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-08       Impact factor: 11.205

9.  Lymphocytic choriomeningitis virus: an underdiagnosed cause of congenital chorioretinitis.

Authors:  M B Mets; L L Barton; A S Khan; T G Ksiazek
Journal:  Am J Ophthalmol       Date:  2000-08       Impact factor: 5.258

10.  Recovery of an arenavirus entirely from RNA polymerase I/II-driven cDNA.

Authors:  Lukas Flatz; Andreas Bergthaler; Juan Carlos de la Torre; Daniel D Pinschewer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-13       Impact factor: 11.205

View more
  6 in total

1.  The ReFRAME library as a comprehensive drug repurposing library to identify mammarenavirus inhibitors.

Authors:  Yu-Jin Kim; Beatrice Cubitt; Emily Chen; Mitchell V Hull; Arnab K Chatterjee; Yingyun Cai; Jens H Kuhn; Juan C de la Torre
Journal:  Antiviral Res       Date:  2019-07-11       Impact factor: 5.970

Review 2.  Improving the Breadth of the Host's Immune Response to Lassa Virus.

Authors:  Juan Carlos Zapata; Sandra Medina-Moreno; Camila Guzmán-Cardozo; Maria S Salvato
Journal:  Pathogens       Date:  2018-10-28

Review 3.  Hemorrhagic Fever-Causing Arenaviruses: Lethal Pathogens and Potent Immune Suppressors.

Authors:  Morgan E Brisse; Hinh Ly
Journal:  Front Immunol       Date:  2019-03-13       Impact factor: 7.561

4.  Isolation of Reconstructed Functional Ribonucleoprotein Complexes of Machupo Virus.

Authors:  Jesse D Pyle; Sean P J Whelan
Journal:  J Virol       Date:  2021-08-25       Impact factor: 5.103

5.  Activation of the STAT3 Signaling Pathway by the RNA-Dependent RNA Polymerase Protein of Arenavirus.

Authors:  Qingxing Wang; Qilin Xin; Weijuan Shang; Weiwei Wan; Gengfu Xiao; Lei-Ke Zhang
Journal:  Viruses       Date:  2021-05-25       Impact factor: 5.048

6.  A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.

Authors:  Beatrice Cubitt; Emilio Ortiz-Riano; Benson Yh Cheng; Yu-Jin Kim; Charles D Yeh; Catherine Z Chen; N O E Southall; Wei Zheng; Luis Martinez-Sobrido; Juan C de la Torre
Journal:  Antiviral Res       Date:  2019-11-28       Impact factor: 5.970

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.